<DOC>
	<DOCNO>NCT02224170</DOCNO>
	<brief_summary>The primary purpose study compare effect lidocaine dexamethasone postoperative quality recovery laparoscopic cholecystectomy</brief_summary>
	<brief_title>Comparison Effect Quality Recovery Outcome Between Systemic Lidocaine Dexamethasone Patients Undergoing Laparoscopic Cholecystectomy</brief_title>
	<detailed_description />
	<mesh_term>Gallstones</mesh_term>
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>ASA III patient age 20 65 year undergo laparoscopic cholecystectomy due gallbladder polyp asymptomatic gallstone without cholecystitis 1 . Steroid therapy immunocompromised patient 2 . Diabetes mellitus 3 . Allergy lidocaine dexamethasone 4 . Severe renal dysfunction ( serum creatinine 1.6mg/dl ) 5 . Severe liver disease ( liver enzymes two time normal value ) 6 . History atrioventricular block 7 . Have difficulty understand QoR40 ( 40item qualityofrecovery score system ) Korean language 8 . History physicologic disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Dexamethasone</keyword>
	<keyword>Lidocaine</keyword>
	<keyword>Quality Recovery</keyword>
	<keyword>Laparoscopic cholecystectomy</keyword>
</DOC>